Tango Therapeutics (TNGX) vs. CRSP and SMMT: Can Vopimetostat Turn Promising Cancer Data Into an 89% Upside?
Is TNGX a good stock to buy? We came across a bullish thesis on Tango Therapeutics, Inc. on BioEquity Watch’s Substack.
Tango Therapeutics Inc. (TNGX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 2,061 | $51,422 | -70% | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.78 | 10,000 | $37,800.00 | 31,250 | 2024-11-18 | Filing | |
| $3.62 | 10,000 | $36,200.00 | 21,250 | 2024-11-14 | Filing | |
| $6.84 | 500,000 | $3,420,000.00 | 8,198,642 | 2023-10-16 | Filing | |
| $7.07 | 750,000 | $5,302,500.00 | 7,698,642 | 2023-10-13 | Filing | |
| $6.84 | 500,000 | $3,420,000.00 | 8,198,642 | 2023-10-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.32 | 600 | $15,192.00 | 115,743 | 2026-10-01 | Filing | |
| $24.45 | 26,400 | $645,604.08 | 116,343 | 2026-10-01 | Filing | |
| $25.17 | 2,400 | $60,412.32 | 59,121 | 2026-09-22 | Filing | |
| $23.97 | 5,100 | $122,238.33 | 61,521 | 2026-09-22 | Filing | |
| $22.80 | 700 | $15,962.03 | 66,621 | 2026-09-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 595,912 | $14,868,004 | 0.01% | |
| 2. | 478,454 | $11,937,427 | 0.08% | |
| 3. | 81,366 | $2,030,082 | 0% | |
| 4. | 62,319 | $1,554,859 | 0.04% | |
| 5. | 61,636 | $1,537,818 | 0.03% |
News See All
Tango Therapeutics (TNGX) Has Striking Pancreatic Cancer Data. How Much Is Priced In?
A Small Trial Has Created a Large Valuation Test Tango Therapeutics, Inc.
11 Best Cancer Stocks to Invest In Now
Cancer’s Burden Keeps the Search for Better Treatments Urgent For cancer patients, progress means more time, fewer side effects, and a better chance of recovery.
10 Best Biotech Stocks to Invest In According to Billionaires
The race to secure the next blockbuster medicine is giving biotech investors two opportunities to assess: the value a treatment could generate and the price a larger drugmaker might pay to acquire it.
10 Affordable Biotech Stocks to Buy Right Now
In this article, we will take a look at some of the most affordable biotech stocks that are currently offering attractive upside potential.
10 Most Promising Mid-Cap Healthcare Stocks According to Hedge Funds
In this article, we will take a look at some of the best mid-cap healthcare stocks that are being highly favored by hedge funds.
Stifel Remains Bullish on Tango Therapeutics (TNGX)
Tango Therapeutics, Inc. (NASDAQ:TNGX) is one of the best performing healthcare stocks so far in 2026. Stifel lifted the price target on Tango Therapeutics, Inc.
10 Best Performing Healthcare Stocks So Far in 2026
In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2026.
10 Best Performing Stocks of Q1 2026 to Watch for Q2
In this article, we will be looking at the 10 Best Performing Stocks of Q1 2026 to Watch for Q2.
Tango Therapeutics' (TNGX) Sees Cautious Analyst Optimism Following Earnings
Tango Therapeutics Inc. (NASDAQ:TNGX) is one of the 11 Best Day Trading Stocks to Buy Now. Financial firm Mizuho raised its share price target for Tango Therapeutics Inc. (NASDAQ:TNGX) on March 11th.
Hedge Fund Resource Center